ST18 and type 2 diabetes mellitus: It is possible that the downregulation of ST18 coupled with the increased expression of pathways related to lipid metabolism and fatty acid metabolic processes seen in our data demonstrate a shift in energetic substrates from glucose to lipids that is just beginning by mid-gestation and has not reached the lipotoxic levels that Henry et al.’s [35] study achieved in their goal of emulating the environment of type 2 diabetes.